Автор туралы ақпарат

Аметов, А. С

Шығарылым Бөлім Атауы Файл
№ 16 (2012) Articles Nevropatiya i prediabet: eti chasy nachinayut tikat' rano
№ 16 (2012) Articles Pompovaya insulinoterapiya: novye tekhnologii v sovremennoy klinicheskoy praktike
№ 16 (2012) Articles Ratsional'naya farmakoterapiya SD 2 tipa: primenenie ingibitora DPP-4 saksagliptina i metformina v klinicheskoy praktike
№ 5 (2013) Articles SOVETNIK BOLYuSA": EFFEKTIVNOE I BEZOPASNOE UPRAVLENIE POSTPRANDIAL'NOY GLIKEMIEY U PATsIENTOV NA POMPOVOY INSULINOTERAPII
№ 5 (2013) Articles INNOVATsIONNAYa SAKhAROSNIZhAYuShchAYa TERAPIYa: NOVAYa STRATEGIYa DLYa STAROY PROBLEMY
№ 5 (2013) Articles SAKhARNYY DIABET 2 TIPA I NEALKOGOL'NAYa ZhIROVAYa BOLEZN' PEChENI: PRAKTIChESKIE REKOMENDATsII DLYa ENDOKRINOLOGOV
№ 16 (2013) Articles Bazal'naya insulinoterapiya: opyt klinicheskoy praktiki
№ 16 (2013) Articles Preimushchestva novoy fiksirovannoy kombinatsii saksagliptina i metformina modifitsirovannogo vysbozhdeniya v terapii sakharnogo diabeta 2 tipa
№ 16 (2013) Articles Upravlenie lipotoksichnost'yu v debyute sakharnogo diabeta 2 tipa
№ 5 (2014) Articles VLIYaNIE KOMBINATsII METFORMINA I VILDAGLIPTINA NA POKAZATELI UGLEVODNOGO I ZhIROVOGO OBMENOV U BOL'NYKh SAKhARNYM DIABETOM 2 TIPA
№ 16 (2014) Articles Kompleksnoe lechenie erektil'noy disfunktsii u muzhchin s ozhireniem
№ 5 (2015) Articles Preimushchestva fiksirovannoy kombinatsii saksagliptina i metformina modifitsirovannogo vysvobozhdeniya (Kombogliz Prolong) v terapii SD 2 tipa
№ 10 (2015) Articles Ingibitory dipeptidilpeptidazy-4: novye vozmozhnosti effektivnogo glikemicheskogo kontrolya putem korrektsii narusheniy zhirovogo obmena u patsientov s sakharnym diabetom 2 tipa
№ 5 (2016) Articles GLYCEMIC VARIABILITY AS A THERAPEUTIC TARGET IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS
№ 5 (2017) Articles PATHOPHYSIOLOGICAL APPROACH AS A BASIS FOR THE SELECTION OF STRATEGY FOR THE SUCCESS TREATMENT OF TYPE 2 DIABETES MELLITUS
Том 26, № 14 (2019) Articles Early pathogenetic combined therapy of sugar diabetes type 2: focus on insulin resistance